Dipeptidyl peptidase-4 inhibitor use is not associated with elevated risk of severe joint pain in patients with type 2 diabetes: A population-based cohort study

Company Name

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum porta libero erat. Nullam at ipsum quis felis egestas vulputate nec nec ligula.

August 24, 2016

tony w

Pain